Skip to main content

Institutional intelligence for Supreme Industries Limited

Cross-view mutual fund activity and super-investor shareholding · Jun 2026 SHP.

Ownership breakdown

Category totals from the official quarterly Shareholding Pattern filing (Jun 2026). Sums to 100.00%.

  • Promoters48.96%
  • FII17.08%
  • Mutual Funds10.67%
  • DII (ex-MF)8.41%
  • Retail & others14.88%
  • 1% Club 12.22%(subset)

Super Investors and 1% Club names below are disclosed holders at or above 1%. They are subsets of the categories above, not additive. View filing

Holder details (≥1% disclosed names)

Promoters

Promoter & promoter group

48.96%3 named
HolderStakeSharesValue (₹ Cr)
16.17%2,05,42,552₹6.62k Cr
16.17%2,05,37,956₹6.62k Cr
14.20%1,80,41,229₹5.81k Cr

1% Club — Individuals & others

Non-promoter ≥1% holders not matched to a curated profile

12.22%7 named
HolderStakeSharesValue (₹ Cr)
Tracked as Nalanda2.97%37,72,128₹1.22k Cr
2.47%31,43,040₹1.01k Cr
1.65%20,97,037₹675.5 Cr
1.50%19,00,984₹612.3 Cr
1.38%17,55,958₹565.6 Cr
1.21%15,40,693₹496.3 Cr
1.04%13,19,300₹425.0 Cr

FII / FPI

Foreign portfolio investors

17.08%No names

No named holders ≥1% in this bucket.

Retail & others

Holders below 1% disclosure threshold and public non-institutions

14.88%

SEBI requires naming only shareholders with ≥1% stake. The remaining 14.88% includes retail investors, small HNIs, employee trusts, and other holders below the disclosure threshold — aggregated in the official filing.

Mutual Funds

Domestic mutual funds & UTI

10.67%2 named

DII (other)

Insurance, banks, AIF, other domestic institutions

8.41%1 named
HolderStakeSharesValue (₹ Cr)
Tracked as LIC1.03%13,03,560₹419.9 Cr

Super Investors

Curated tracked investor profiles

No names

No curated super investor holds ≥1% in the latest filing. See FII, DII, and mutual fund holders in the sections above.

Shareholding data sourced from NSE/BSE regulatory filings. Category chart uses official filing totals; named holder lists include every disclosed ≥1% position. Not investment advice. See our disclaimer and methodology.